Newron Pharmaceuticals S.p.A. ( NWPHF) - Key Metrics
Stock symbol NWPHF is outdated, potentially delisted? Maybe it is available on other exchange?
NWPHF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.66 | -$0.66 | -$0.05 | -$0.05 |
| 2025Q2 | $0.30 | $0 | $0.84 | $0.83 |
| 2024Q4 | $2.58 | $1.37 | -$0.47 | -$0.47 |
| 2024Q2 | $0.18 | -$0.51 | -$0.48 | -$0.48 |
| 2023Q4 | $0.20 | -$0.52 | -$0.25 | -$0.25 |
NWPHF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 0% | -6.45 |
| 2025Q2 | 0% | -2356.94 |
| 2024Q4 | 0% | 1.70 |
| 2024Q2 | 0% | -4.36 |
| 2023Q4 | 0% | -3.09 |
NWPHF
Price: $20
52 week price:
Earnings Per Share: -0.75 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 416.1 million